← Evidence map

TrialJournal of clinical immunology2026

Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.

David H McDermott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41904735